Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial

被引：0
|
作者：
Sanne Y. Smith-Apeldoorn
Jolien K. E. Veraart
Jeanine Kamphuis
Antoinette D. I. van Asselt
Daan J. Touw
Marije aan het Rot
Robert A. Schoevers
机构：
[1] University of Groningen,Department of Psychiatry
[2] University Medical Center Groningen,Department of Psychiatry, PsyQ Haaglanden
[3] Parnassia Psychiatric Institute,Department of Epidemiology
[4] University of Groningen,Department of Clinical Pharmacy and Pharmacology
[5] University Medical Center Groningen,Department of Psychology
[6] University of Groningen,undefined
[7] University Medical Center Groningen,undefined
[8] University of Groningen,undefined
来源：
BMC Psychiatry | / 19卷
关键词：
Esketamine; Oral administration; Clinical trial; Treatment-resistant depression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
    Smith-Apeldoorn, Sanne Y.
    Veraart, Jolien K. E.
    Kamphuis, Jeanine
    van Asselt, Antoinette D. I.
    Touw, Daan J.
    aan Het Rot, Marije
    Schoevers, Robert A.
    [J]. BMC PSYCHIATRY, 2019, 19 (01)
  • [2] Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
    Sanne Y. Smith-Apeldoorn
    Jolien K. E. Veraart
    Jeanine Kamphuis
    Antoinette D. I. van Asselt
    Daan J. Touw
    Marije aan het Rot
    Robert A. Schoevers
    [J]. BMC Psychiatry, 20
  • [3] Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial (vol 19, 375, 2019)
    Smith-Apeldoorn, Sanne Y.
    Veraart, Jolien K. E.
    Kamphuis, Jeanine
    van Asselt, Antoinette D. I.
    Touw, Daan J.
    Rot, Marije Aan Het
    Schoevers, Robert A.
    [J]. BMC PSYCHIATRY, 2020, 20 (01)
  • [4] Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression A Randomized Clinical Trial
    Daly, Ella J.
    Singh, Jaskaran B.
    Fedgchin, Maggie
    Cooper, Kimberly
    Lim, Pilar
    Shelton, Richard C.
    Thase, Michael E.
    Winokur, Andrew
    Van Nueten, Luc
    Manji, Husseini
    Drevets, Wayne C.
    [J]. JAMA PSYCHIATRY, 2018, 75 (02) : 139 - 148
  • [5] A Randomized Controlled Trial of Ketamine for Adolescent Treatment-Resistant Depression
    Dwyer, Jennifer
    Yip, Sarah
    Sanacora, Gerard
    Bloch, Michael
    [J]. NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S95 - S95
  • [6] Approval of esketamine for treatment-resistant depression
    Singh, Jaskaran B.
    Daly, Ella J.
    Mathews, Maju
    Fedgchin, Maggie
    Popova, Vanina
    Hough, David
    Drevets, Wayne C.
    [J]. LANCET PSYCHIATRY, 2020, 7 (03): : 232 - 235
  • [7] Esketamine/ketamine for treatment-resistant depression
    Lacerda, Acioly L. T.
    [J]. BRAZILIAN JOURNAL OF PSYCHIATRY, 2020, 42 (06) : 579 - 580
  • [8] Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension
    Smith-Apeldoorn, Sanne Y.
    Veraart, Jolien K. E.
    Kamphuis, Jeanine
    Spijker, Jan
    van der Meij, Annemarie
    van Asselt, Antoinette D. I.
    aan het Rot, Marije
    Schoevers, Robert A.
    [J]. MOLECULAR PSYCHIATRY, 2024,
  • [9] Intranasal esketamine for treatment-resistant depression
    Sobieraj, A.
    Wang, E.
    Kohl, P.
    Kirsch, B.
    Slapakova, L.
    Schuele, C.
    Falkai, P.
    [J]. EUROPEAN PSYCHIATRY, 2020, 63 : S117 - S117
  • [10] Esketamine (Spravato) for Treatment-Resistant Depression
    Jalloh, Mohamed
    [J]. AMERICAN FAMILY PHYSICIAN, 2020, 101 (06) : 339 - 340
12345